Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2008

View Archived Issues

Memory presents an update on the company's collaborative and proprietary clinical programs

Novel antiangiogenic agent profiled at Amgen

Researchers identify novel inhibitors of orphan SF-1 nuclear receptor

Antimalarial agent may be useful for the treatment of toxoplasmosis

Eisai submits application in Japan for oral jelly formulation of Aricept in Alzheimer's disease

Lilly and Transition enter agreement for TT-223 and other gastrin-based therapies in diabetes

Neurochem to initiate second phase III clinical trial of Kiacta in amyloid A amyloidosis

Power3 initiates clinical validation study of NuroPro in Alzheimer's and Parkinson's disease

Teva reports negative final results from a phase II trial of glatiramer acetate in ALS

FDA grants approval to Diamyd to initiate phase III clinical study of Diamyd in diabetes

FDA licenses sanofi-aventis' Daptacel as fifth consecutive DTaP vaccine dose for children

Silence and AstraZeneca to collaborate in developing novel delivery systems for siRNA molecules

Jazz presents an update on pipeline progress

New treatments for inflammatory conditions such as rheumatoid arthritis claimed in recent patents

Novel analgesic agents disclosed in recent Boehringer Ingelheim and GSK patents

EntreMed presents update on clinical programs

Abraxis files marketing application for Abraxane for breast cancer in Japan

Novel botulinum toxin type A treatment improves aspects of plantar fasciitis

Benefits lasting 6 months seen with duloxetine in fibromyalgia patients

Nuvelo to discontinue alfimeprase development

FDA issues approvable letter for ceftobiprole, an anti-MRSA broad-spectrum antibiotic

Studies point to lacosamide efficacy in painful diabetic neuropathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...